Biography
Industry Evolution, Incentives for Innovation, Healthcare Markets
Erasmus School of Economics
Associate professor | Applied Economics
- bhaskarabhatla@ese.eur.nl
- Room
- T18-29
- Location
- Burg. Oudlaan 50, Rotterdam
More information
Work
- Gianluca Antonecchia & Ajay Bhaskarabhatla (2023) - How firms compete when they set identical prices: Nonprice strategies in the Indian biscuit industry - Journal of Economics and Management Strategy, 1 - doi: 10.1111/jems.12518 - [link]
- Mirko Benischke, Ajay Bhaskarabhatla & Rajani Singh (2023) - The Effect of Incoming Board Interlocks With Public Firms on Private Firms’ Survival: Large-Scale Evidence From India - Journal of Management - doi: 10.1177/01492063231164971 - [link]
- Mirko Benischke & Ajay Bhaskarabhatla (2022) - Negative Incentives and Regulatory Capture: Noncompliance with Price Ceilings on Essential Medicines in India - Journal of Management Studies - doi: 10.1111/joms.12885 - [link]
- Ajay Bhaskarabhatla, Priyatam Anurag, Chirantan Chatterjee & Enrico Pennings (2021) - How does regulation impact strategic repositioning by firms across submarkets? Evidence from the Indian pharmaceutical industry - Strategy Science, 6 (3), 209-227 - doi: 10.1287/stsc.2020.0121 - [link]
- Ajay Bhaskarabhatla, Luis Cabral, Deepak Hegde & Thomas Peeters (2021) - Are inventors or firms the engines of innovation? - Management Science, 67 (6), 3899-3920 - doi: 10.1287/mnsc.2020.3646 - [link]
- Ajay Bhaskarabhatla (2020) - Maximum Resale Price Maintenance and Retailer Cartel Profits: Evidence from the Indian Pharmaceutical Industry - Antitrust Law Journal, 83 (1), 41-73 - [link]
- A Adbi, Ajay Bhaskarabhatla & C Chatterjee (2018) - Stakeholder Orientation and Market Impact: Evidence from India - Journal of Business Ethics, 161, 479-496 - doi: 10.1007/s10551-018-3919-x - [link]
- Ajay Bhaskarabhatla (2018) - Regulating Pharmaceutical Prices in India Policy Design, Implementation and Compliance - doi: 10.1007/978-3-319-93393-1 - [link]
- Ajay Bhaskarabhatla & Chirantan Chatterjee (2017) - Whither competition law in Indian pharmaceutical markets?: Evidence from arbitration data of CCI and COMPAT - Journal of Antitrust Enforcement, 5 (2), 291-298 - doi: 10.1093/jaenfo/jnx007 - [link]
- Ajay Bhaskarabhatla, P Anurag, C Chatterjee & Enrico Pennings (2017) - Mitigating Regulatory Impact: The Case of Partial Price Controls on Metformin in India - Health Policy and Planning, 32 (2), 194-204 - doi: 10.1093/heapol/czw109 - [link]
- Thomas Peeters & Ajay Bhaskarabhatla (2022) - ERIM Top Article Award 2022
Seminar Sustainable Firm Strategy
- Level
- master
- Year Level
- master
- Year
- 2023
- Course Code
- FEM11167
Corporate Innovation and Venture Capital
- Level
- master
- Year Level
- master
- Year
- 2023
- Course Code
- FEM11088
Introduction to Strategy Economics
- Year Level
- bachelor 3, bachelor 3, bachelor 3, pre-master, bachelor 3
- Year
- 2023
- Course Code
- FEB13044
f